Cases 21 - 30 of 72
Bayer Intellectual Property GMBH et al v. Breckenridge Pharmaceutical Inc.
as 1:2016cv00628
Plaintiff:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Breckenridge Pharmaceutical Inc.
as 1:2016cv00431
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
OTSUKA PHARMACEUTICAL CO., LTD. v. STASON INDUSTRIAL CORP. et al
as 1:2016cv00555
Plaintiff:
OTSUKA PHARMACEUTICAL CO., LTD.
Defendant:
STASON INDUSTRIAL CORP., STASON PHARMACEUTICALS INC., ZHEJIANG JINHUA CONBA BIO-PHARM CO., LTD and others
Cause Of Action: 35 U.S.C. § 271
OTSUKA PHARMACEUTICAL CO., LTD. v. STASON INDUSTRIAL CORP. et al
as 1:2016cv00557
Plaintiff:
OTSUKA PHARMACEUTICAL CO., LTD.
Defendant:
STASON INDUSTRIAL CORP., STASON PHARMACEUTICALS INC., ZHEJIANG JINHUA CONBA BIO-PHARM CO., LTD and others
Cause Of Action: 35 U.S.C. § 271
OSI Pharmaceuticals, LLC et al v. Breckenridge Pharmaceutical Inc. et al
as 1:2015cv01063
Plaintiff:
OSI Pharmaceuticals, LLC , Pfizer Inc. and Genentech Inc.
Defendant:
Breckenridge Pharmaceutical Inc. and Natco Pharma Ltd.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc.
as 1:2015cv01039
Plaintiff:
Par Pharmaceutical Inc. and Alkermes Pharma Ireland Limited
Defendant:
Breckenridge Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Intellectual Property GMBH et al v. Aurobindo Pharma Limited et al
as 1:2015cv00902
Plaintiff:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Limited , Aurobindo Pharma USA Inc. , Breckenridge Pharmaceutical Inc. and others
Counter_claimant:
Sigmapharm Laboratories LLC and Prinston Pharmaceutical Inc.
Counter_defendant:
Bayer Intellectual Property GMBH , Bayer Pharma AG and Janssen Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
OTSUKA PHARMACEUTICAL CO., LTD. v. STANDARD CHEM. & PHARM. CO., LTD et al
as 1:2015cv06353
Counter Defendant:
OTSUKA PHARMACEUTICAL CO., LTD.
Defendant:
STANDARD CHEM. & PHARM. CO., LTD, BRECKENRIDGE PHARMACEUTICAL, INC., ZHEJIANG JINHUA CONBA BIO-PHARM CO. LTD. and others
Counter Claimant:
STASON PHARMACEUTICALS INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Par Pharmaceutical Inc. et al v. Breckenridge Pharmaceutical Inc. et al
as 1:2015cv00486
Plaintiff:
Par Pharmaceutical Inc. and Alkermes Pharma Ireland Limited
Defendant:
Breckenridge Pharmaceutical Inc., TWi Pharmaceuticals Inc. and TWi Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271
TAKEDA GMBH et al v. BRECKENRIDGE PHARMACEUTICAL INC.
as 3:2015cv03382
Plaintiff:
TAKEDA GMBH , ASTRAZENECA PHARMACEUTICALS LP and ASTRAZENECA UK LIMITED
Defendant:
BRECKENRIDGE PHARMACEUTICAL INC.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
